उत्पाद विवरण
Dastila 50 mg Tablet is a targeted therapy designed to combat specific forms of cancer, primarily those associated with chronic myeloid leukemia (CML) and certain types of acute lymphoblastic leukemia (ALL), thanks to its active ingredient, dasatinib. This innovative medication works by inhibiting the activity of abnormal proteins that promote cancer cell growth, thereby slowing down or halting the progression of the disease. While Dastila can be an effective treatment option, it is essential to be aware of potential side effects, which may include fatigue, nausea, and an increased risk of infections. Patients should also be monitored for signs of bleeding or bruising, as dasatinib can affect blood cell counts. It is crucial to follow your healthcare provider's instructions and undergo regular check-ups to ensure optimal results and safety during treatment. If you have any pre-existing conditions or are taking other medications, discuss these with your doctor to avoid any harmful interactions. By targeting cancer at its source, Dastila 50 mg Tablet represents a significant advancement in personalized cancer care, offering hope for many patients navigating their treatment journey.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
मुझे निःशुल्क कॉल करें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese